These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 9717832

  • 1. Systemic interleukin 2 therapy for human prostate tumors in a nude mouse model.
    Triest JA, Grignon DJ, Cher ML, Kocheril SV, Montecillo EJ, Talati B, Tekyi-Mensah S, Pontes JE, Hillman GG.
    Clin Cancer Res; 1998 Aug; 4(8):2009-14. PubMed ID: 9717832
    [Abstract] [Full Text] [Related]

  • 2. Neutron or photon irradiation for prostate tumors: enhancement of cytokine therapy in a metastatic tumor model.
    Hillman GG, Maughan RL, Grignon DJ, Yudelev M, Rubio J, Tekyi-Mensah S, Layer A, Che M, Forman JD.
    Clin Cancer Res; 2001 Jan; 7(1):136-44. PubMed ID: 11205901
    [Abstract] [Full Text] [Related]

  • 3. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
    Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ, Fidler IJ.
    Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238.
    Plonowski A, Schally AV, Nagy A, Sun B, Szepeshazi K.
    Cancer Res; 1999 Apr 15; 59(8):1947-53. PubMed ID: 10213505
    [Abstract] [Full Text] [Related]

  • 5. Development of seven new human prostate tumor xenograft models and their histopathological characterization.
    van Weerden WM, de Ridder CM, Verdaasdonk CL, Romijn JC, van der Kwast TH, Schröder FH, van Steenbrugge GJ.
    Am J Pathol; 1996 Sep 15; 149(3):1055-62. PubMed ID: 8780407
    [Abstract] [Full Text] [Related]

  • 6. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
    Jenkins DE, Hornig YS, Oei Y, Dusich J, Purchio T.
    Breast Cancer Res; 2005 Sep 15; 7(4):R444-54. PubMed ID: 15987449
    [Abstract] [Full Text] [Related]

  • 7. Improved metastatic animal model of human prostate carcinoma using surgical orthotopic implantation (SOI).
    Chang XH, Fu YW, Na WL, Wang J, Sun H, Cai L.
    Anticancer Res; 1999 Sep 15; 19(5B):4199-202. PubMed ID: 10628375
    [Abstract] [Full Text] [Related]

  • 8. A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice.
    Xu X, Kreye E, Kuo CB, Walker AM.
    Cancer Res; 2001 Aug 15; 61(16):6098-104. PubMed ID: 11507059
    [Abstract] [Full Text] [Related]

  • 9. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P, Karashima T, Kim SJ, Kedar D, Mian B, Huang S, Baker C, Fan Z, Hicklin DJ, Pettaway CA, Dinney CP.
    Clin Cancer Res; 2002 Aug 15; 8(8):2714-24. PubMed ID: 12171905
    [Abstract] [Full Text] [Related]

  • 10. An orthotopic nude mouse model of oral tongue squamous cell carcinoma.
    Myers JN, Holsinger FC, Jasser SA, Bekele BN, Fidler IJ.
    Clin Cancer Res; 2002 Jan 15; 8(1):293-8. PubMed ID: 11801572
    [Abstract] [Full Text] [Related]

  • 11. Traffic to lymph nodes of PC-3 prostate tumor cells in nude mice visualized using the luciferase gene as a tumor cell marker.
    Rubio N, Villacampa MM, Blanco J.
    Lab Invest; 1998 Oct 15; 78(10):1315-25. PubMed ID: 9800957
    [Abstract] [Full Text] [Related]

  • 12. Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice.
    Smith PC, Keller ET.
    Prostate; 2001 Jun 15; 48(1):47-53. PubMed ID: 11391686
    [Abstract] [Full Text] [Related]

  • 13. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F, Lee J, Lu S, Pettaway CA, Dong Z.
    Clin Cancer Res; 2005 Jun 15; 11(12):4512-20. PubMed ID: 15958637
    [Abstract] [Full Text] [Related]

  • 14. Prostate cancer treatment is enhanced by genistein in vitro and in vivo in a syngeneic orthotopic tumor model.
    Wang Y, Raffoul JJ, Che M, Doerge DR, Joiner MC, Kucuk O, Sarkar FH, Hillman GG.
    Radiat Res; 2006 Jul 15; 166(1 Pt 1):73-80. PubMed ID: 16808622
    [Abstract] [Full Text] [Related]

  • 15. Different effect of paclitaxel on primary tumor mass, tumor cell contents, and metastases for four experimental human prostate tumors expressing luciferase.
    El Hilali N, Rubio N, Blanco J.
    Clin Cancer Res; 2005 Feb 01; 11(3):1253-8. PubMed ID: 15709196
    [Abstract] [Full Text] [Related]

  • 16. The suppression of human prostate tumor growth in mice by the intratumoral injection of a slow-release polymeric paste formulation of paclitaxel.
    Jackson JK, Gleave ME, Yago V, Beraldi E, Hunter WL, Burt HM.
    Cancer Res; 2000 Aug 01; 60(15):4146-51. PubMed ID: 10945622
    [Abstract] [Full Text] [Related]

  • 17. Differential metastasis-associated gene analysis of prostate carcinoma cells derived from primary tumor and spontaneous lymphatic metastasis in nude mice with orthotopic implantation of PC-3M cells.
    Chu JH, Sun ZY, Meng XL, Wu JH, He GL, Liu GM, Jiang XR.
    Cancer Lett; 2006 Feb 20; 233(1):79-88. PubMed ID: 15885894
    [Abstract] [Full Text] [Related]

  • 18. Comparative intraosseal growth of human prostate cancer cell lines LNCaP and PC-3 in the nude mouse.
    Soos G, Jones RF, Haas GP, Wang CY.
    Anticancer Res; 1997 Feb 20; 17(6D):4253-8. PubMed ID: 9494517
    [Abstract] [Full Text] [Related]

  • 19. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA, Harb JF, Barroso U, He Z, Grignon DJ, Cher ML.
    Cancer Res; 1999 Apr 15; 59(8):1987-93. PubMed ID: 10213511
    [Abstract] [Full Text] [Related]

  • 20. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY, Haack H, Crowley D, Barry M, Bronson RT, Hynes RO.
    Cancer Res; 2005 Nov 01; 65(21):9789-98. PubMed ID: 16267000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.